紫龙金片治疗晚期恶性肿瘤临床观察

Clinical observation on treatment of advanced malignant tumor with Zilongjin Tablets

目的观察紫龙金片治疗晚期恶性肿瘤的临床疗效及不良反应。方法对照组52例采用常规支持对症治疗,治疗组53例在常规支持对症治疗的基础上,加用紫龙金片口服,2周为1个疗程,治疗2个疗程。结果治疗组实体瘤近期疗效中稳定例数明显高于对照组(P<0.05),生活质量改善也优于对照组(P<0.01)。结论紫龙金片治疗晚期恶性肿瘤有较好疗效,且无明显不良反应。

Objective To observe the clinical curative effect and adverse reaction of Zilongjin Tablets in the treatment of advanced malignant tumor. Methods Fifty-three patients were treated with Zilongjin Tablets orally in the treatment group based on routine treatment, while 52 patients in the control group were treated only with conventional treatment. Each group was treated for two courses（28 d）. Results The clinical response cases of stable disease in the short-term efficacy of the treatment group were more than that in the control group（P 0.05）. In the meanwhile, the life quality improvement was better than that of the control group（P 0.01）. Conclusion Zilongjin Tablets showed a better curative effect in the treatment of advanced malignant neoplasms without obvious adverse reaction.